Singapore, Oct. 3 -- Pier 88 Health, a digital health company dedicated to reshaping chronic pain management and bringing breakthrough global medical innovations to Greater China, and Israel-based Theranica, a prescribed digital therapeutics company, have announced that the Nerivio(R)REN wearable, a novel treatment of migraine, has received regulatory approval from China's National Medical Products Administration (NMPA).
The registration certificate marks the first and only approval in China of a wearable migraine device using the Remote Electrical Neuromodulation (REN) technology. This drug-free, smartphone-controlled prescribed therapy provides a clinically validated, self-administered solution for people living with migraine.
By offe...
Click here to read full article from source
To read the full article or to get the complete feed from this publication, please
Contact Us.